文献速递消化道出血消化内镜肝病

超声内镜引导下弹簧圈注射治疗胃静脉曲张:美国首项多中心经验(附视频)

EUS-guided coil injection therapy in the management of gastric varices: the first U.S. multicenter experience (with video).
PubMed 文献 · Gastrointest Endosc · 2023-07-31

该回顾性分析纳入2018至2022年美国10家三级中心接受EUS引导下弹簧圈注射治疗(EUS-COIL)的106例出血性或高危胃静脉曲张患者,技术成功率100%、临床成功率88.7%,术中不良事件2例(1.8%)、术后5例(4.7%),复发出血15例(14.1%),高量与低量中心结局无显著差异。

要点

  • EUS-COIL技术成功率100%,临床成功率88.7%。
  • 术中不良事件2例(1.8%),术后不良事件5例(4.7%),其中3例为轻度。
  • 复发出血15例(14.1%),其中80%经重复EUS-COIL再治疗成功。

核心结论

  • 美国多中心EUS-COIL治疗胃静脉曲张经验证实技术成功率和临床成功率高、不良事件低。
  • 高量与低量中心之间结局无显著差异。
  • 重复EUS-COIL似乎是复发出血胃静脉曲张患者的有效挽救选择。
  • 作者认为需进一步前瞻性研究比较该方式与常用其他干预措施。

研究设计与样本

  • 回顾性分析,纳入2018至2022年美国10家三级中心因出血性或出血高风险胃静脉曲张接受EUS-COIL的患者。
  • 共纳入106例患者,平均年龄60.4±12.8岁,女性占41.5%。
  • EUS-COIL采用22G或19G FNA针注射0.018英寸或0.035英寸止血弹簧圈。

主要发现

  • 胃静脉曲张病因以肝硬化最常见(71.7%),酒精为最常见病因(43.4%)。
  • 71.7%表现为急性胃静脉曲张出血,需重症监护病房停留和/或输血。
  • 最常见类型为孤立性胃静脉曲张1型(60.4%)。
  • 平均注射弹簧圈3.8±3枚,总平均长度44.7±46.1 cm,82%患者辅助注射组织胶或可吸收明胶海绵。
  • 技术成功率100%,临床成功率88.7%;复发出血15例(14.1%),平均32天,其中80%经重复EUS-COIL再治疗成功。

关键数值与推荐

  • 技术成功定义为EUS引导下弹簧圈成功置入曲张静脉且多普勒血流减弱。
  • 临床成功定义为出血停止(如存在)和/或干预后30天无出血。
  • 术中不良事件(肺栓塞和FNA针道胃静脉曲张出血)2例(1.8%),术后不良事件5例(4.7%),其中3例为轻度。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Despite the significant morbidity associated with gastric variceal bleeding, there is a paucity of high-quality data regarding optimal management. EUS-guided coil injection therapy (EUS-COIL) has recently emerged as a promising endoscopic modality for the treatment of gastric varices (GV), particularly compared with traditional direct endoscopic glue injection. Although there are data on the feasibility and safety of EUS-COIL in the management of GV, these have been limited to select centers with particular expertise. The aim of this study was to report the first U.S. multicenter experience of EUS-COIL for the management of GV. METHODS: This retrospective analysis included patients with bleeding GV or GV at risk of bleeding who underwent EUS-COIL at 10 U.S. tertiary care centers between 2018 and 2022. Baseline patient and procedure-related information was obtained. EUS-COIL entailed the injection of .018 inch or .035 inch hemostatic coils using a 22-gauge or 19-gauge FNA needle. Primary outcomes were technical success (defined as successful deployment of coil into varix under EUS guidance with diminution of Doppler flow), clinical success (defined as cessation of bleeding if present and/or absence of bleeding at 30 days' postintervention), and intraprocedural and postprocedural adverse events. RESULTS: A total of 106 patients were included (mean age 60.4 ± 12.8 years; 41.5% female). The most common etiology of GV was cirrhosis (71.7%), with alcohol being the most common cause (43.4%). Overall, 71.7% presented with acute GV bleeding requiring intensive care unit stay and/or blood transfusion. The most common GV encountered were isolated GV type 1 (60.4%). A mean of 3.8 ± 3 coils were injected with a total mean length of 44.7 ± 46.1 cm. Adjunctive glue or absorbable gelatin sponge was injected in 82% of patients. Technical success and clinical success were 100% and 88.7%, respectively. Intraprocedural adverse events (pulmonary embolism and GV bleeding from FNA needle access) occurred in 2 patients (1.8%), and postprocedural adverse events occurred in 5 (4.7%), of which 3 were mild. Recurrent bleeding was observed in 15 patients (14.1%) at a mean of 32 days. Eighty percent of patients with recurrent bleeding were successfully re-treated with repeat EUS-COIL. No significant differences were observed in outcomes between high-volume (>15 cases) and low-volume (<7 cases) centers. CONCLUSIONS: This U.S. multicenter experience on EUS-COIL for GV confirms high technical and clinical success with low adverse events. No significant differences were seen between high- and low-volume centers. Repeat EUS-COIL seems to be an effective rescue option for patients with recurrent bleeding GV. Further prospective studies should compare this modality versus other interventions commonly used for GV.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Bazarbashi AN, Aby ES, Mallery JS, et al. EUS-guided coil injection therapy in the management of gastric varices: the first U.S. multicenter experience (with video). Gastrointest Endosc. 2023. PMID: 37532106. doi:10.1016/j.gie.2023.07.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。